Shelley Shapiro (Eric Shen)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Combination Therapy

Systemic Sclerosis

Pulmonary Hypertension

Top Venues

Pulmonary circulation

Annals of the American Thoracic Society

Journal of cardiovascular pharmacology and therapeutics

American journal of respiratory and critical care medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Oksana A Shlobin, Shelley Shapiro, Stephen John Wort, Lucilla Piccari, John A Scandurra, Paul M Hassoun, Sylvia M Nikkho, Steven D Nathan
Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary Hypertension. Pulmonary circulation 14 (1) (2024)
Oksana A Shlobin, Shelley Shapiro, Stephen John Wort, Lucilla Piccari, John A Scandurra, Paul M Hassoun, Sylvia M Nikkho, Steven D Nathan
Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary Hypertension. Pulmonary circulation 14 (1) (2024)
Steven D Nathan, Boris Medarov, Lawrence Ho, John Kingrey, Taekwon Hong, Youlan Rao, Shelley Shapiro, Peter Smith, Chunqin Deng, Aaron B Waxman
A Novel Approach to Clinical Change Endpoints: A Win Ratio Analysis of the INCREASE Trial. Annals of the American Thoracic Society (2023)
Sylvia M Nikkho, Manuel J Richter, Shelley Shapiro, Steven H Abman, Katerina Antoniou, Jonathan Chung, Peter Fernandes, Paul Hassoun, Howard M Lazarus, Horst Olschewski, Lucilla Piccari, Mitchell Psotka, Rajan Saggar, Oksana A Shlobin, Norman Stockbridge, Patrizio Vitulo, Carmine Dario Vizza, Stephen J Wort, Steven D Nathan
Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative-Group 3 pulmonary hypertension. Pulmonary circulation 12 (3) (2022)
Stacy Mandras, Gabor Kovacs, Horst Olschewski, Meredith Broderick, Andrew Nelsen, Shelley Shapiro, Hunter Champion
Combination Therapy in Pulmonary Arterial Hypertension-Targeting the Nitric Oxide and Prostacyclin Pathways. Journal of cardiovascular pharmacology and therapeutics 26 (5) (2021)
Shelley Shapiro, Stacy Mandras, Ricardo Restrepo-Jaramillo, Meredith Broderick, Youlan Rao, Dasom Lee, Andrew C Nelsen
Survival and drug persistence in patients receiving inhaled treprostinil at doses greater than 54 µg (nine breaths) four times daily. Pulmonary circulation 11 (4) (2021)
Steven D Nathan, Victor F Tapson, Jean Elwing, Franz Rischard, Jinesh Mehta, Shelley Shapiro, Shelley Shapiro, Chunqin Deng, Peter Smith, Aaron B Waxman
Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension Due to Parenchymal Lung Disease in the INCREASE Trial. American journal of respiratory and critical care medicine (2021)
Gautam Ramani, Steven J Cassady, Shelley Shapiro, Meredith Broderick, Allie Wasik, Qun Sui, Andrew Nelsen
Novel dose-response analyses of treprostinil in pulmonary arterial hypertension and its effects on six-minute walk distance and hospitalizations. Pulmonary circulation 10 (3) (2020)